Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease

Bilon Khambu, Shengmin Yan, Nazmul Huda, Gang Liu, Xiao Ming Yin

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Autophagy is an evolutionarily conserved intracellular degradative function that is important for liver homeostasis. Accumulating evidence suggests that autophagy is deregulated during the progression and development of alcoholic and non-alcoholic liver diseases. Impaired autophagy prevents the clearance of excessive lipid droplets (LDs), damaged mitochondria, and toxic protein aggregates, which can be generated during the progression of various liver diseases, thus contributing to the development of steatosis, injury, steatohepatitis, fibrosis, and tumors. In this review, we look at the status of hepatic autophagy during the pathogenesis of alcoholic and non-alcoholic liver diseases. We also examine the mechanisms of defects in autophagy, and the hepato-protective roles of autophagy in non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD), focusing mainly on steatosis and liver injury. Finally, we discuss the therapeutic potential of autophagy modulating agents for the treatment of these two common liver diseases.

Original languageEnglish (US)
Pages (from-to)112-119
Number of pages8
JournalLiver Research
Volume2
Issue number3
DOIs
StatePublished - Sep 2018

Fingerprint

Alcoholic Liver Diseases
Autophagy
Liver Diseases
Fatty Liver
Poisons
Liver
Wounds and Injuries
Non-alcoholic Fatty Liver Disease
Mitochondria
Homeostasis
Fibrosis

Keywords

  • Alcoholic liver disease (ALD)
  • Autophagy
  • Liver injury
  • Non-alcoholic fatty liver disease (NAFLD)
  • Steatosis

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease. / Khambu, Bilon; Yan, Shengmin; Huda, Nazmul; Liu, Gang; Yin, Xiao Ming.

In: Liver Research, Vol. 2, No. 3, 09.2018, p. 112-119.

Research output: Contribution to journalReview article

Khambu, Bilon ; Yan, Shengmin ; Huda, Nazmul ; Liu, Gang ; Yin, Xiao Ming. / Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease. In: Liver Research. 2018 ; Vol. 2, No. 3. pp. 112-119.
@article{b3e163cc912a4df0af4559bd8bb4e165,
title = "Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease",
abstract = "Autophagy is an evolutionarily conserved intracellular degradative function that is important for liver homeostasis. Accumulating evidence suggests that autophagy is deregulated during the progression and development of alcoholic and non-alcoholic liver diseases. Impaired autophagy prevents the clearance of excessive lipid droplets (LDs), damaged mitochondria, and toxic protein aggregates, which can be generated during the progression of various liver diseases, thus contributing to the development of steatosis, injury, steatohepatitis, fibrosis, and tumors. In this review, we look at the status of hepatic autophagy during the pathogenesis of alcoholic and non-alcoholic liver diseases. We also examine the mechanisms of defects in autophagy, and the hepato-protective roles of autophagy in non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD), focusing mainly on steatosis and liver injury. Finally, we discuss the therapeutic potential of autophagy modulating agents for the treatment of these two common liver diseases.",
keywords = "Alcoholic liver disease (ALD), Autophagy, Liver injury, Non-alcoholic fatty liver disease (NAFLD), Steatosis",
author = "Bilon Khambu and Shengmin Yan and Nazmul Huda and Gang Liu and Yin, {Xiao Ming}",
year = "2018",
month = "9",
doi = "10.1016/j.livres.2018.09.004",
language = "English (US)",
volume = "2",
pages = "112--119",
journal = "Liver Research",
issn = "2542-5684",
number = "3",

}

TY - JOUR

T1 - Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease

AU - Khambu, Bilon

AU - Yan, Shengmin

AU - Huda, Nazmul

AU - Liu, Gang

AU - Yin, Xiao Ming

PY - 2018/9

Y1 - 2018/9

N2 - Autophagy is an evolutionarily conserved intracellular degradative function that is important for liver homeostasis. Accumulating evidence suggests that autophagy is deregulated during the progression and development of alcoholic and non-alcoholic liver diseases. Impaired autophagy prevents the clearance of excessive lipid droplets (LDs), damaged mitochondria, and toxic protein aggregates, which can be generated during the progression of various liver diseases, thus contributing to the development of steatosis, injury, steatohepatitis, fibrosis, and tumors. In this review, we look at the status of hepatic autophagy during the pathogenesis of alcoholic and non-alcoholic liver diseases. We also examine the mechanisms of defects in autophagy, and the hepato-protective roles of autophagy in non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD), focusing mainly on steatosis and liver injury. Finally, we discuss the therapeutic potential of autophagy modulating agents for the treatment of these two common liver diseases.

AB - Autophagy is an evolutionarily conserved intracellular degradative function that is important for liver homeostasis. Accumulating evidence suggests that autophagy is deregulated during the progression and development of alcoholic and non-alcoholic liver diseases. Impaired autophagy prevents the clearance of excessive lipid droplets (LDs), damaged mitochondria, and toxic protein aggregates, which can be generated during the progression of various liver diseases, thus contributing to the development of steatosis, injury, steatohepatitis, fibrosis, and tumors. In this review, we look at the status of hepatic autophagy during the pathogenesis of alcoholic and non-alcoholic liver diseases. We also examine the mechanisms of defects in autophagy, and the hepato-protective roles of autophagy in non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD), focusing mainly on steatosis and liver injury. Finally, we discuss the therapeutic potential of autophagy modulating agents for the treatment of these two common liver diseases.

KW - Alcoholic liver disease (ALD)

KW - Autophagy

KW - Liver injury

KW - Non-alcoholic fatty liver disease (NAFLD)

KW - Steatosis

UR - http://www.scopus.com/inward/record.url?scp=85072277421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072277421&partnerID=8YFLogxK

U2 - 10.1016/j.livres.2018.09.004

DO - 10.1016/j.livres.2018.09.004

M3 - Review article

AN - SCOPUS:85072277421

VL - 2

SP - 112

EP - 119

JO - Liver Research

JF - Liver Research

SN - 2542-5684

IS - 3

ER -